Article Details
Retrieved on: 2021-03-15 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In contrast to many machine learning algorithms, Valence's “few-shot” drug discovery platform can design drugs based on relatively small amounts of ...
Article found on: parkinsonsnewstoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here